IGKV1D-22 and breast cancer: Other natural compounds, such as luteolin and quercetin, have also inhibited human breast cancer cell proliferation through the downregulation of cell surface α9-nAChR subunit expression in human breast cancer cells, and the combined treatment of cells with luteolin and quercetin synergistically inhibited AKT activation [28].